Wells Fargo Initiates Coverage On Repligen with Overweight Rating, Announces Price Target of $185
Portfolio Pulse from richadhand@benzinga.com
Wells Fargo analyst Timothy Daley has initiated coverage on Repligen (NASDAQ:RGEN) with an Overweight rating and a price target of $185.
July 20, 2023 | 10:53 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Repligen receives an Overweight rating from Wells Fargo with a price target of $185.
The Overweight rating from Wells Fargo indicates a positive outlook for Repligen. The price target of $185 suggests that the analyst believes there is significant upside potential for the stock. This could lead to increased investor interest and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100